Clinical Trial

Biomarkers to Enhance Early Schizophrenia Treatment

Study acronym: BEEST
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-12; most recent amendment 2026-06-11.
Status change: Not Yet Recruiting → Recruiting 2026-04-23
Trial Details
NCT Number NCT06969755
Lead Sponsor Northwell Health
Collaborators: National Institute of Mental Health (NIMH)
Conditions Schizophenia Disorder
Enrollment 180 participants
Start Date 2024-09-04
Primary Completion 2030-07-30 (estimated)
Study Completion 2030-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-31